Search research articles
Contact Us
Filters
Showing results (51-60 of 139) with videos related to
Page
of 14
Sort By:
Liver Research (Beijing, China)
|
July 3, 2026
Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transporters
Su Guan, Xin Li, Yimei Wang, et al.
Non-Coding RNA
|
November 25, 2024
Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures
Frank Yiyang Mao, Mei-Juan Tu, Gavin McAllister Traber, et al.
Current Drug Metabolism
|
October 26, 2011
Humanized transgenic mouse models for drug metabolism and pharmacokinetic research
Hong-Wu Shen, Xi-Ling Jiang, Frank J Gonzalez, et al.
Current Drug Metabolism
|
October 15, 2010
Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions
Hong-Wu Shen, Xi-Ling Jiang, Jerrold C Winter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 1, 2007
Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice
Melanie A Felmlee, Hoi-Kei Lon, Frank J Gonzalez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 9, 2013
Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status
Xi-Ling Jiang, Hong-Wu Shen, Donald E Mager, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 22, 2022
Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models
Mei-Juan Tu, Colleen M Yi, Gavin M Traber, et al.
Pharmacogenetics
|
June 5, 2003
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase
Ai-Ming Yu, Jeffrey R Idle, Tomas Herraiz, et al.
International Journal of Molecular Sciences
|
September 9, 2020
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)
Neelu Batra, Cristabelle De Souza, Jyoti Batra, et al.
Frontiers in Molecular Biosciences
|
March 30, 2026
Efficiency and safety of five different agents for <i>in vivo</i> delivery of novel bioengineered RNAi molecules
Su Guan, Mei-Juan Tu, Yan-Ju Li, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 139) with videos related to
Sort By:
Page
of 14
Liver Research (Beijing, China)
|
July 3, 2026
Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transporters
Su Guan, Xin Li, Yimei Wang, et al.
Non-Coding RNA
|
November 25, 2024
Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures
Frank Yiyang Mao, Mei-Juan Tu, Gavin McAllister Traber, et al.
Current Drug Metabolism
|
October 26, 2011
Humanized transgenic mouse models for drug metabolism and pharmacokinetic research
Hong-Wu Shen, Xi-Ling Jiang, Frank J Gonzalez, et al.
Current Drug Metabolism
|
October 15, 2010
Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions
Hong-Wu Shen, Xi-Ling Jiang, Jerrold C Winter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 1, 2007
Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice
Melanie A Felmlee, Hoi-Kei Lon, Frank J Gonzalez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 9, 2013
Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status
Xi-Ling Jiang, Hong-Wu Shen, Donald E Mager, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 22, 2022
Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models
Mei-Juan Tu, Colleen M Yi, Gavin M Traber, et al.
Pharmacogenetics
|
June 5, 2003
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase
Ai-Ming Yu, Jeffrey R Idle, Tomas Herraiz, et al.
International Journal of Molecular Sciences
|
September 9, 2020
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)
Neelu Batra, Cristabelle De Souza, Jyoti Batra, et al.
Frontiers in Molecular Biosciences
|
March 30, 2026
Efficiency and safety of five different agents for <i>in vivo</i> delivery of novel bioengineered RNAi molecules
Su Guan, Mei-Juan Tu, Yan-Ju Li, et al.
Page
of 14